肠道激素刺激作为口服交付治疗方法
1UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium; WEL Research Institute, Avenue Pasteur, 6, 1300 Wavre, Belgium.
刺激肠道激素增强了口服的输送,为治疗2型糖尿病等慢性疾病提供了注射的替代方案. 这种方法旨在通过共同刺激内源性激素分泌来增加的生物可用性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 药物输送系统 药物输送系统
背景情况:
- 口服配送在达到治疗性全身度方面面临挑战.
- 慢性疾病如2型糖尿病通常需要每天注射.
- 肠道激素模仿剂,如葡萄糖类-1 (GLP-1) 和GLP-2,为替代性输送提供了机会.
研究的目的:
- 探索肠道激素刺激作为口服递送的治疗策略.
- 通过内源性激素分泌来提高的生物可用性的方法.
- 讨论这种方法对胃肠道疾病的临床潜力和局限性.
主要方法:
- 研究的重点是刺激从肠内分泌L细胞分泌的肠道激素.
- 研究调查了共同刺激策略,以达到治疗性水平.
- 对口服递送系统的现有研究进行批判性分析.
主要成果:
- 肠道激素刺激显示有望改善口服的生物可用性.
- 协同刺激可能会导致治疗相关的全身度.
- 这种方法特别适用于像GLP-1和GLP-2这样的.
结论:
- 可以通过刺激肠道激素分泌来增强治疗性的口服输送.
- 这一策略为慢性疾病的亲肠道治疗提供了一个潜在的替代方案.
- 需要进一步的研究来解决局限性问题,并推进胃肠道疾病的临床实施.
更多相关视频
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Hormone Secretion
Humoral...
Hormonal Regulation
Drug Delivery: Enteral Route
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
